Axtria Unveils LUCCID: The Future of Clinical Data Handling
Axtria's Groundbreaking Launch of LUCCID
Axtria Inc., an innovative leader in data analytics for life sciences, has recently launched LUCCID, a transformative solution harnessing the power of GenAI to automate the extraction of unstructured clinical data. This revolutionary technology promises to achieve an impressive accuracy rate of over 90%, significantly enhancing the efficiency of clinical data management.
Automating Clinical Data Extraction
The core capability of Axtria's LUCCID lies in its ability to identify and extract clinical concepts from unstructured data sources, converting them into structured formats that integrate seamlessly into downstream clinical trial systems. The significance of this advancement cannot be underestimated; a substantial portion of clinical research budgets is dedicated to activities such as data abstraction, source data validation, and monitoring. By automating these processes, LUCCID is poised to reduce both the time and costs associated with managing patient study data considerably.
Addressing Challenges in Clinical Trials
It is important to note that approximately 80% of clinical trial data is derived from unstructured sources. Therefore, LUCCID addresses a critical bottleneck—the labor-intensive task of transforming unstructured data into formats usable for clinical trials. By employing advanced large language models that are clinically trained, LUCCID ensures that the extraction process is not only quick but also precise, grounded in expertise related to biomedical information.
Transforming Traditional Data Management Practices
With LUCCID, Axtria is redefining the landscape of clinical data extraction. What has historically been seen as a slow, often error-prone endeavor has now transitioned into a streamlined and efficient automated workflow. Research findings showcasing LUCCID's effectiveness will be shared at prominent conferences, marking a pivotal moment in the evolution of clinical data management.
Features of Axtria's LUCCID Solution
Axtria is proud to collaborate with 16 of the top 20 global life sciences companies, continuously driving digital transformation within the sector. The launch of LUCCID reflects Axtria's commitment to providing innovative solutions that facilitate the complex process of clinical data management. Key features include:
- High accuracy in data extraction based on advanced AI algorithms.
- Efficient integration with existing FHIR-based EHR-to-EDC systems.
- Automated workflows that minimize the need for manual data handling.
About Axtria and Its Solutions
Axtria is recognized as a premier provider of cloud-based software solutions tailored for the life sciences industry. The company has evolved from its roots as a trusted consulting entity to a global leader in pharmaceutical management software. By utilizing years of domain knowledge, Axtria helps pharmaceutical companies navigate the complexities of the market—from initial brand launches to product retirements. Notable offerings from Axtria encompass:
- Axtria InsightsMAx.ai for cloud analytics.
- Axtria SalesIQ™ focused on optimizing sales operations.
- Axtria CustomerIQ™ which enhances customer engagement via AI.
- Axtria MarketingIQ™ tailored for effective marketing strategies.
- Axtria DataMAx™ and DataMAx™ for Emerging Pharma to ensure robust data management.
A Commitment to Positive Change
In addition to their technological prowess, Axtria is dedicated to the principles outlined in the United Nations Global Compact. Commitment to human rights, labor standards, environmental stewardship, and anti-corruption is at the heart of Axtria’s operational ethos. By aligning their strategies with social goals, they aim to make meaningful contributions to the healthcare ecosystem while enhancing patient outcomes through effective data utilization.
Frequently Asked Questions
What is LUCCID?
LUCCID is an AI-powered solution by Axtria that automates the extraction of unstructured clinical data from electronic health records, ensuring high accuracy.
How does LUCCID improve clinical data management?
LUCCID transforms manual processes into automated workflows, significantly decreasing time and costs associated with data management in clinical trials.
What percentage of clinical trial data is unstructured?
Approximately 80% of clinical trial data comes from unstructured sources, which LUCCID aims to streamline and integrate effectively.
Who does Axtria collaborate with?
Axtria partners with 16 of the top 20 life sciences companies globally, providing cloud-based solutions and expertise in pharmaceutical management.
What is Axtria's mission?
Axtria's mission is to harness data science and software to enhance patient outcomes by connecting patients with the right therapies in an efficient manner.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.